Source: Annual Congress 2003 - Assessment and pathological processes of lung injury
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Barát, E. Huszár, G. Vass, M. Valyon, K. Czebe, E. Csiszér, I. Horváth (Budapest, Hungary). Exhaled biomarkers in patients with cystic fibrosis and lung transplant recipients. Eur Respir J 2003; 22: Suppl. 45, 1747

Member's Comments

No comment yet.

Related content which might interest you: Exhaled NO measurements may be useful in assessing acute lung injury in donors and lung allograft recipients Source: Eur Respir J 2002; 20: Suppl. 38, 348s Year: 2002 Survival and lung function in double lung transplant recipients with cystic fibrosis Source: International Congress 2017 – From donor lung selection and organ preservation to lung transplant outcome Year: 2017 Exhaled breath particles - a potential noninvasive method to detect and monitor chronic allograft dysfunction in lung transplant recipients Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome Year: 2020 Factors affecting lung function in adult cystic fibrosis patients after lung transplantation. Source: International Congress 2018 – Evolving approaches to differential diagnosis Year: 2018 Cystic fibrosis lung disease and lung transplantation Source: ERS Skills Course 2016 Year: 2016 Exhaled carbon monoxide correlates with airway neutrophilia in patients with chronic allograft dysfunction (BOS) after lung transplantation Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 Ciliary function in paediatric non cystic fibrosis (CF) lung transplant recipients Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings Year: 2009 Breath VOC patterns of lung transplant recipients with and without chronic lung allograft dysfunction (CLAD) Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017 Lung function tests and survival in idiopathic pulmonary fibrosis after lung transplantation Source: Eur Respir J 2005; 26: Suppl. 49, 335s Year: 2005 Exhaled volatile organic compounds as biomarkers for respiratory diseases Source: Eur Respir Monogr 2010; 49: 130-139 Year: 2010 Inhaled colistin following lung transplantation in colonised cystic fibrosis patients Source: Eur Respir J 2013; 42: 542-544 Year: 2013 Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 347s Year: 2002 Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Lung function in children with cystic fibrosis liver disease Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Clinical characteristics and pulmonary function in patients with pulmonary fibrosis assessed for lung transplant Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010 Exercise capacity following lung transplantation in cystic fibrosis patients Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 Outcomes and survival following lung transplantation in non-cystic fibrosis bronchiectasis Source: ERJ Open Res, 8 (1) 00607-2021; 10.1183/23120541.00607-2021 Year: 2022 The relationship between CT assessed lung damage, and inflammatory markers in exhaled breath condensate of cystic fibrosis patients Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007 CF lung disease and lung transplantation Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine Year: 2017 CF lung disease and lung transplantation Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019 Year: 2019